varenicline has been researched along with Pulmonary Disease, Chronic Obstructive in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (12.00) | 29.6817 |
| 2010's | 35 (70.00) | 24.3611 |
| 2020's | 9 (18.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andelius, DK; Hilberg, O; Ibsen, R; Løkke, A | 1 |
| Guo, K; Li, J; Li, X; Li, Y; Shang, X; Wang, S; Wei, X; Yang, C; Yang, K; Zhang, X | 1 |
| Laucho-Contreras, ME; Montes de Oca, M | 1 |
| Carico, E; Pezzuto, A | 1 |
| Brestec, AL; Couturaud, F; Dansou, A; Dewitte, JD; Dion, A; Gagnadoux, F; Hayem-Vannimenus, C; Jouneau, S; Larhantec, G; Le Mao, R; Leroyer, C; Magnan, A; Paleiron, N; Proust, A; Roche, N; Sanchez, O; Tromeur, C | 1 |
| Davies, NM; Itani, T; Jones, T; Martin, RM; Munafò, MR; Taylor, AE; Taylor, GM; Thomas, KH; Windmeijer, F | 1 |
| Hadda, V; Mittal, S; Mohan, A; Rathi, V | 1 |
| Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC | 1 |
| Boezen, HM; Bos, JH; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B | 1 |
| Kotz, D; Sheikh, A; Simpson, CR; van Schayck, OCP; Viechtbauer, W; West, R | 1 |
| Acuña Izcaray, A; Alfageme Michavila, I; Buljubasich, D; Casas, A; Chatkin, JM; de Granda Orive, JI; Guerreros Benavides, A; Jiménez Ruiz, CA; Noé, V; Núñez-Sánchez, I; Paez Espinel, N; Palomar Lever, A; Riesco Miranda, JA; Sánchez-Angarita, E; Sansores, RH; Zabert, G | 1 |
| Kress, CM; Obi, NU; Prochazka, AV | 1 |
| Daniil, Z; Gourgoulianis, KI; Hatzoglou, C; Ioannidis, V; Politis, A | 1 |
| Abramson, MJ; Bonevski, B; Eustace, P; George, J; Holland, AE; Liang, J; Mahal, A; Paul, E; Phillips, K; Russell, GM; Wilson, S; Zwar, NA | 1 |
| Abad, E; Armengol, O; Domenech Del Rio, A; Garcia Rueda, M; Jiménez-Fuentes, MA; Jiménez-Ruiz, CA; Lázaro Asegurado, L; Martinez Muñiz, MA; Peña, T; Riesco Miranda, JA; Rodriguez Garcia, C; Rodríguez Gonzalez, E; Sellarés, J | 1 |
| Davies, NM; Jones, T; Martin, RM; Munafò, MR; Taylor, AE; Taylor, GMJ; Thomas, KH; Windmeijer, F | 1 |
| Clark, AJ; Johnsen, SP; Lange, P; Thomsen, RW; Tøttenborg, SS | 1 |
| Cazzola, M; Hernández Zenteno, RJ; Lara, DF; Matera, MG; Pérez Padilla, JR; Pineda, JR; Sansores, RH; Trujillo, FF; Venegas, AR | 1 |
| D'Ascanio, M; Grieco, A; Pezzuto, A; Ricci, A | 1 |
| Tønnesen, P | 1 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S | 1 |
| Fagerström, KO; Jiménez-Ruiz, CA | 1 |
| Pezzuto, A; Spoto, C; Tonini, G; Vincenzi, B | 1 |
| Daughton, DM; Rennard, SI | 1 |
| Hergel, LL; Nielsen, G; Poulsen, PB; Ringbæk, T; Spillemose, H; Strand, M; Wedell-Wedellsborg, D | 1 |
| Andreas, S; Reinhardt, C | 1 |
| Tashkin, DP | 1 |
| Altet-Gomez, N; Barrueco, M; de Higes-Martinez, E; Granda-Orive, JI; Jiménez-Ruiz, CA; Lorza-Blasco, JJ; Oyagüez, I; Rejas, J; Riesco-Miranda, JA; Signes-Costa, J; Solano-Reina, S | 1 |
| Au, DH; Collins, MP; Feemster, LC; Melzer, AC | 1 |
| Uruma, R | 1 |
| Arellano-Rocha, R; García-Gómez, L; Noé-Díaz, V; Pérez Bautista, O; Ramírez-Venegas, A; Sansores, RH; Velázquez Uncal, M | 1 |
| Ojo, O; Temitayo Orisasami, I | 1 |
| Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC | 1 |
| Cuesta, H; Kolman-Taddeo, D; Leone, FT; Morrison, M; Patterson, F; Satti, A; Zaslav, DS | 1 |
| Cedillo, S; Fernández de Bobadilla, J; Jiménez-Ruiz, CA; Rejas-Gutiérrez, J; Sicras-Mainar, A | 1 |
| Chitkara, R; Krishna, G; Mohanasundaram, UM | 1 |
| Ebbert, JO; Hays, JT | 1 |
| Laniado-Laborín, R | 1 |
| Aubin, HJ; Benhaddi, H; Bolin, K; de Nigris, E; Marbaix, S; Mork, AC; Wilson, K | 1 |
| Burke, MV; Ebbert, JO; Hays, J; Wyatt, KD; Zirakzadeh, A | 1 |
| Hays, JT; Lawrence, D; Lee, TC; Ma, W; Rennard, S; Tashkin, DP | 1 |
| Kotz, D; van Schayck, OCP | 1 |
| Lawrence, D; Lee, TC; Marton, JP; Rennard, S; Tashkin, DP; Taylor Hays, J | 1 |
| Lock, K; Murphy, D; Riesco, JA; Wilson, K | 1 |
| Cicero Guerrero, A; Cristobal Fernández, M; Jiménez Ruiz, CA; Lopez Gonzalez, G; Mayayo Ulibarri, M; Ramos Pinedo, A | 1 |
| Cuesta, G; Lovato, P; Lutz, MA | 2 |
| Cesario, A; Granone, P; Lococo, F; Petracca-Ciavarella, L; Russo, P | 1 |
| Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C | 1 |
| Hering, T | 1 |
15 review(s) available for varenicline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effects of different interventions on smoking cessation in chronic obstructive pulmonary disease patients: A systematic review and network meta-analysis.
Topics: Humans; Network Meta-Analysis; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Varenicline | 2022 |
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
[Smoking cessation--what's new?].
Topics: Benzazepines; Combined Modality Therapy; Electronic Nicotine Delivery Systems; Humans; Motivational Interviewing; Nicotinic Agonists; Patient Compliance; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Respiratory Function Tests; Smoking Cessation; Varenicline | 2015 |
Smoking Cessation in Chronic Obstructive Pulmonary Disease.
Topics: Combined Modality Therapy; Counseling; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |
[Smoking cessation for COPD].
Topics: Health Education; Humans; Pulmonary Disease, Chronic Obstructive; Risk; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Evaluating the effectiveness of smoking cessation in the management of COPD.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Humans; Nicotinic Agonists; Nurse's Role; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Varenicline | 2016 |
Smoking cessation for people with chronic obstructive pulmonary disease.
Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2016 |
Smoking cessation therapy with varenicline.
Topics: Benzazepines; Humans; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Brain; Coronary Artery Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
Topics: Benzazepines; Cardiovascular Diseases; Drug Labeling; Humans; Mental Disorders; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
5 trial(s) available for varenicline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial.
Topics: Aged; Counseling; Disease Progression; Early Medical Intervention; Female; Hospitalization; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference
Topics: Adult; Aftercare; Asthma; Behavior Therapy; Combined Modality Therapy; Community-Acquired Infections; Comorbidity; Disease Progression; Female; Hospitalization; Humans; Inpatients; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Motivational Interviewing; Odds Ratio; Patient Preference; Pneumonia; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Referral and Consultation; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2018 |
Diagnosing COPD and supporting smoking cessation in general practice: evidence-practice gaps.
Topics: Adult; Aged; Australia; Evidence-Based Medicine; Female; General Practice; Humans; Hypnosis; Male; Middle Aged; Professional Practice Gaps; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Spirometry; Varenicline | 2018 |
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
Topics: Aged; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; France; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Respiratory Function Tests; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Spirometry; Treatment Outcome; United States; Varenicline | 2011 |
Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.
Topics: Benzazepines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinoxalines; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2011 |
30 other study(ies) available for varenicline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
National Epidemiological Case-Control Study of Pharmacological Smoking Cessation Treatment in Danish Patients with Chronic Obstructive Pulmonary Disease.
Topics: Case-Control Studies; Denmark; Female; Humans; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Smoking cessation and vaccination.
Topics: Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Vaccination; Varenicline | 2023 |
Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: Functional analysis.
Topics: Adult; Blood Gas Analysis; Carbon Monoxide; Case-Control Studies; Exhalation; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Oximetry; Oxygen; Plethysmography; Predictive Value of Tests; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Retrospective Studies; Sleep Apnea Syndromes; Smokers; Smoking Cessation; Smoking Cessation Agents; Time Factors; Varenicline; Walk Test | 2020 |
Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.
Topics: Adult; Cohort Studies; Electronic Health Records; Female; Humans; Male; Mortality; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2020 |
Varenicline for Long Term Abstinence in Acute COPD- the Dilemma Continues.
Topics: Hospitalization; Humans; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Varenicline | 2020 |
Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting.
Topics: Benzazepines; Bupropion; Cohort Studies; Humans; Netherlands; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.
Topics: Adult; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2017 |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Topics: Biomarkers; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Counseling; Evidence-Based Medicine; Humans; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2017 |
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2017 |
Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study.
Topics: Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Cessation Agents; Treatment Outcome; Varenicline | 2017 |
The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records.
Topics: Body Mass Index; Case-Control Studies; Cause of Death; Cohort Studies; Electronic Health Records; Hospitalization; Longitudinal Studies; Mortality; Myocardial Infarction; Primary Health Care; Propensity Score; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United Kingdom; Varenicline; Weight Gain | 2018 |
Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study.
Topics: Adult; Age Factors; Aged; Bupropion; Denmark; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Sex Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Socioeconomic Factors; Varenicline | 2018 |
Varenicline for long term smoking cessation in patients with COPD.
Topics: Adult; Airway Obstruction; Carbon Monoxide; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2018 |
Functional benefit of smoking cessation in severe COPD patients undergoing bronchial valve implantation.
Topics: Aged; Female; Humans; Male; Prostheses and Implants; Prosthesis Implantation; Pulmonary Disease, Chronic Obstructive; Respiratory System; Smoking Cessation; Smoking Cessation Agents; Treatment Outcome; Varenicline | 2019 |
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level.
Topics: Benzazepines; Carbon Monoxide; Carboxyhemoglobin; Carcinoembryonic Antigen; Combined Modality Therapy; Cough; Counseling; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Vital Capacity | 2013 |
Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Counseling; Denmark; Dopamine Uptake Inhibitors; Female; General Practice; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2015 |
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Female; Health Care Costs; Health Expenditures; Humans; Male; Markov Chains; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline | 2015 |
Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Admission; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; United States Department of Veterans Affairs; Varenicline | 2016 |
Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Motivation; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2016 |
Smoking Cessation in Pulmonary Care Subjects: A Mixed Methods Analysis of Treatment-Seeking Participation and Preferences.
Topics: Aged; Black or African American; Coronary Artery Disease; Exercise; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Hospitals, Urban; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Patient Preference; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Smoking; Smoking Cessation; Varenicline | 2017 |
Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
Topics: Adult; Aged; Cardiovascular Diseases; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Health Care Costs; Humans; Insurance, Health, Reimbursement; Male; Markov Chains; Middle Aged; Models, Economic; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Spain; Varenicline | 2017 |
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Europe; Female; Heart Diseases; Humans; Incidence; Lung Neoplasms; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Stroke; Varenicline; Young Adult | 2009 |
What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD?
Topics: Benzazepines; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2011 |
A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
Topics: Benzazepines; Cost-Benefit Analysis; Europe; Female; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2011 |
Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Topics: Adult; Aged; Benzazepines; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican Republic; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Coronary Disease; Costs and Cost Analysis; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Middle Aged; Nicaragua; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Stroke; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2012 |
Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
Topics: Benzazepines; Bupropion; Chromosomes, Human, Pair 15; Genetic Loci; Genome-Wide Association Study; Humans; Multigene Family; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
[Giving up smoking is crucial for COPD patients].
Topics: Benzazepines; Bupropion; Family Practice; Humans; Patient Care Team; Patient Education as Topic; Physician-Patient Relations; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline | 2007 |